Paul Tudor Jones’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
6CM
Paul Tudor Jones's KYNB Position: Q1 2024 in Review
Paul Tudor Jones sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 1,928 shares — an estimated $42.7K sold.
Paul Tudor Jones first reported a position in KYNB in Q3 2015 and held it in 18 quarters. The position peaked at $1.59M in Q1 2022. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.
- Paul Tudor Jones reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
- Paul Tudor Jones sold 1,928 Kyntra Bio shares in Q1 2024, an estimated $42.7K.
- Paul Tudor Jones first reported a position in Kyntra Bio in Q3 2015 and held it in 18 quarters.
- Paul Tudor Jones's Kyntra Bio position peaked at $1.59M in Q1 2022.
- 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.
Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.